The DOI matches its Crossref record; 55 of the 58 references it cites were found in a registry or an index.
Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models
Open accessAbstract
High-grade serous ovarian carcinoma presents significant clinical and therapeutic challenges. Although the traditional model of carcinogenesis has focused on the ovary as a tumor initiation site, recent studies suggest that there may be additional sites of origin outside the ovary, namely the secretory cells of the fallopian tube. Our study demonstrates that high-grade serous tumors can originate in fallopian tubal secretory epithelial cells and also establishes serous tubal intraepithelial carcinoma as the precursor lesion to high-grade serous ovarian and peritoneal carcinomas in animal models targeting the Brca, Tp53, and Pten genes. These findings offer an avenue to address clinically important questions that are critical for cancer prevention and early detection in women carrying BRCA1 and BRCA2 mutations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Conditional knockout mice, using the Cre-lox system for cell type specificity, have been used to reproduce oncogenic mutations and HR defects to study ovarian cancer development and responses to clinically relevant treatments such as platin-based drugs and PARPis (Szabova et al., 2012; Perets et al., 2013; Szabova et al., 2014; Zhai et al., 2017).”
From Three-dimensional modelling of ovarian cancer: from cell lines to organoids for discovery and personalized medicine (2022) · cites this paper as Perets et al., 2013
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerami, E., Gao, J., Dogrusoz, U., Gross, B. E., Sumer, S. O., Aksoy, B. A., Jacobsen, A., Byrne, C. J., Heuer, M. L., Larsson, E., et al. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-12-0095 · Cited by 17,455
Siegel, R., Naishadham, D., & Jemal, A. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20138 · Cited by 10,679
Integrated genomic analyses of ovarian carcinoma
Perou, C. M. (2019) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/hvp3-wg08 · Cited by 7,927
Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy
Farmer, H., McCabe, N., Lord, C. J., Tutt, A. N. J., Johnson, D. A., Richardson, T. B., Santarosa, M., Dillon, K. J., Hickson, I., Knights, C., et al. (2005) · Nature · doi:10.1038/nature03445 · Cited by 6,683
Generalized lacZ expression with the ROSA26 Cre reporter strain
Soriano, P. (1999) · Nature Genetics · doi:10.1038/5007 · Cited by 5,237
Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers
Fong, P. C., Boss, D. S., Yap, T. A., Tutt, A., Wu, P., Mergui-Roelvink, M., Mortimer, P., Swaisland, H., Lau, A., O'Connor, M. J., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0900212 · Cited by 3,634
Rethinking ovarian cancer: recommendations for improving outcomes
Vaughan, S., Coward, J. I. G., Bast, R. C., Berchuck, A., Berek, J. S., Brenton, J. D., Coukos, G., Crum, C. P., Drapkin, R., Etemadmoghadam, D., et al. (2011) · Nature reviews. Cancer · doi:10.1038/nrc3144 · Cited by 1,484
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome
Olive, K. P., Tuveson, D. A., Ruhe, Z. C., Yin, B., Willis, N. A., Bronson, R. T., Crowley, D., & Jacks, T. (2004) · Cell · doi:10.1016/j.cell.2004.11.004 · Cited by 1,308
Alsop, K., Fereday, S., Meldrum, C. J., DeFazio, A., Emmanuel, C., George, J., Dobrovic, A., Birrer, M. J., Webb, P. M., Stewart, C. J. R., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.39.8545 · Cited by 1,204
Kindelberger, D. W., Lee, Y., Miron, A., Hirsch, M. S., Feltmate, C. M., Medeiros, F., Callahan, M. J., Garner, E. O., Gordon, R. W., Birch, C., et al. (2007) · The American Journal of Surgical Pathology · doi:10.1097/01.pas.0000213335.40358.47 · Cited by 1,114
Cited by
Sorted by citations
Items 101–200 of 600
Yee, C., Dickson, K.-A., Muntasir, M. N., Ma, Y., & Marsh, D. J. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.836984 · Cited by 66
Molecular targeting of glutaminase sensitizes ovarian cancer cells to chemotherapy
Masamha, C. P., & LaFontaine, P. R. (2018) · Journal of Cellular Biochemistry · doi:10.1002/jcb.26814 · Cited by 66
Yamamoto, C. M., Oakes, M., Murakami, T., Muto, M. G., Berkowitz, R. S., & Ng, S. (2018) · Journal of Ovarian Research · doi:10.1186/s13048-018-0391-2 · Cited by 66
Martins, F. C., Couturier, D., Paterson, A., Karnezis, A. N., Chow, C., Nazeran, T. M., Odunsi, A., Gentry‐Maharaj, A., Vrvilo, A., Hein, A., et al. (2020) · British Journal of Cancer · doi:10.1038/s41416-020-0900-0 · Cited by 67
Ovulation and extra-ovarian origin of ovarian cancer
Yang‐Hartwich, Y., Gurrea-Soteras, M., Sumi, N. J., Joo, W. D., Holmberg, J. C., Craveiro, V., Alvero, A. B., & Mor, G. (2014) · Scientific Reports · doi:10.1038/srep06116 · Cited by 65
Lawrenson, K., Li, Q., Kar, S., Seo, J.-H., Tyrer, J. P., Spindler, T. J., Lee, J. S., Chen, Y., Karst, A. M., Drapkin, R., et al. (2015) · Nature Communications · doi:10.1038/ncomms9234 · Cited by 65
Mensah, L. B., Morton, S. W., Li, J., Xiao, H., Quadir, M., Elias, K. M., Penn, E. E., Richson, A. K., Ghoroghchian, P. P., Liu, J. F., et al. (2019) · Bioengineering & Translational Medicine · doi:10.1002/btm2.10131 · Cited by 62
Nagaraj, A. B., Knarr, M., Sekhar, S. C., Connor, R. S., Joseph, P. L., Kovalenko, O., Fleming, A., Surti, A., Nurmemmedov, E., Beltrame, L., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-2041 · Cited by 63
Sulaiman, S. A., Mutalib, N. A., & Jamal, R. A. (2016) · Frontiers in Pharmacology · doi:10.3389/fphar.2016.00271 · Cited by 64
Shang, S., Yang, J., Jazaeri, A. A., Duval, A. J., Tufan, T., Fischer, N. L., Benamar, M., Guessous, F., Lee, I.-Y., Campbell, R. M., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0215 · Cited by 67
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
McCloskey, C. W., Rodriguez, G. M., Galpin, K. J. C., & Vanderhyden, B. C. (2018) · Cancers · doi:10.3390/cancers10080244 · Cited by 64
A role for PAX8 in the tumorigenic phenotype of ovarian cancer cells
Palma, T. D., Lucci, V., de Cristofaro, T., Filippone, M. G., & Zannini, M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-292 · Cited by 60
Kohler, R. S., Kettelhack, H., Knipprath-Mészáros, A. M., Fedier, A., Schoetzau, A., Jacob, F., & Heinzelmann-Schwarz, V. A. (2017) · Gynecologic Oncology · doi:10.1016/j.ygyno.2017.02.016 · Cited by 60
Hellner, K., Miranda, F., Fotso, D. C., Herrero‐González, S., Hayden, D. M., Tearle, R. G., Artibani, M., Carrami, E. M., Williams, R. M., Gaitskell, K. L., et al. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.06.048 · Cited by 60
Hao, D., Li, J., Jia, S., Meng, Y., Zhang, C., Wang, L., & Di, L. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-0638 · Cited by 59
Yucer, N., Ahdoot, R., Workman, M. J., Laperle, A., Recouvreux, M. S., Kurowski, K., Naboulsi, D. J., Liang, V., Qu, Y., Plummer, J., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.110146 · Cited by 58
Klinkebiel, D. L., Zhang, W., Akers, S. N., Odunsi, K. O., & Karpf, A. R. (2016) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0097 · Cited by 59
Lawrenson, K., Fonseca, M. A., Liu, A. Y., Dezem, F. S., Lee, J. M., Lin, X., Corona, R. I., Abbasi, F., Vavra, K. C., Dinh, H. Q., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.10.122 · Cited by 59
Histones and Their Modifications in Ovarian Cancer – Drivers of Disease and Therapeutic Targets
Marsh, D. J., Shah, J. S., & Cole, A. J. (2014) · Frontiers in Oncology · doi:10.3389/fonc.2014.00144 · Cited by 58
The transcription factor PAX8 promotes angiogenesis in ovarian cancer through interaction with SOX17
Chaves‐Moreira, D., Mitchell, M. A., Arruza, C., Rawat, P., Sidoli, S., Nameki, R. A., Reddy, J., Corona, R. I., Afeyan, L. K., Klein, I. A., et al. (2022) · Science Signaling · doi:10.1126/scisignal.abm2496 · Cited by 64
Loessner, D., Holzapfel, B. M., & Clements, J. A. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.06.001 · Cited by 57
Hooda, J., Novak, M., Salomon, M. P., Matsuba, C., Ramos, R. I., MacDuffie, E., Song, M., Hirsch, M. S., Lester, J., Parkash, V., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-2297 · Cited by 56
Jo, A., Green, A., Medina, J. E., Iyer, S., Öhman, A., McCarthy, E. T., Reinhardt, F., Gerton, T. J., Demehin, D., Mishra, R. K., et al. (2023) · Advanced Science · doi:10.1002/advs.202301930 · Cited by 55
Regulation of invasion and peritoneal dissemination of ovarian cancer by mesothelin manipulation
Coelho, R., Ricardo, S., Amaral, A. L., Huang, Y.-L., Nunes, M., Neves, J. P., Mendes, N., López, M. N., Bartosch, C., Ferreira, V., et al. (2020) · Oncogenesis · doi:10.1038/s41389-020-00246-2 · Cited by 55
Irodi, A., Rye, T., Herbert, K., Churchman, M., Bartos, C., Mackean, M., Nussey, F., Herrington, C. S., Gourley, C., & Hollis, R. L. (2020) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.16264 · Cited by 54
Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition
Iwanicki, M., Chen, H., Iavarone, C., Zervantonakis, I. K., Muranen, T. E., Novak, M., Ince, T. A., Drapkin, R., & Brugge, J. S. (2016) · JCI Insight · doi:10.1172/jci.insight.86829 · Cited by 54
Erriquez, J., Becco, P., Olivero, M., Ponzone, R., Maggiorotto, F., Ferrero, A., Scalzo, M. S., Canuto, E. M., Sapino, A., di Cantogno, L. V., et al. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.06.025 · Cited by 52
Ren, Y. A., Mullany, L. K., Liu, Z., Herron, A. J., Wong, K., & Richards, J. S. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-1046 · Cited by 53
Blanco, L. Z., Kuhn, E., Morrison, J. C., Bahadirli-Talbott, A., Sehdev, A. E. S., & Kurman, R. J. (2017) · Modern Pathology · doi:10.1038/modpathol.2016.219 · Cited by 53
Methylation and ovarian cancer: Can DNA methylation be of diagnostic use? (Review)
Hentze, J. L., Høgdall, C. K., & Høgdall, E. V. S. (2019) · Molecular and Clinical Oncology · doi:10.3892/mco.2019.1800 · Cited by 55
Role of cystathionine beta synthase in lipid metabolism in ovarian cancer
Chakraborty, P. K., Xiong, X., Mustafi, S. B., Saha, S., Dhanasekaran, D. N., Mandal, N. A., McMeekin, S., Bhattacharya, R., & Mukherjee, P. (2015) · Oncotarget · doi:10.18632/oncotarget.5424 · Cited by 51
The fallopian tube as origin of ovarian cancer: Change of diagnostic and preventive strategies
Kyo, S., Ishikawa, N., Nakamura, K., & Nakayama, K. (2019) · Cancer Medicine · doi:10.1002/cam4.2725 · Cited by 52
Mutant p53 expression in fallopian tube epithelium drives cell migration
Quartuccio, S. M., Karthikeyan, S., Eddie, S. L., Lantvit, D. D., hAinmhire, E. Ó., Modi, D., Wei, J., & Burdette, J. E. (2015) · International Journal of Cancer · doi:10.1002/ijc.29528 · Cited by 51
Ghosh, A., Syed, S. M., Kumar, M., Carpenter, T. J., Teixeira, J. M., Houairia, N., Negi, S., & Tanwar, P. S. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107631 · Cited by 50
Targeting progesterone signaling prevents metastatic ovarian cancer
Kim, O., Park, E. Y., Kwon, S. Y., Shin, S., Emerson, R. E., Shin, Y.-H., DeMayo, F. J., Lydon, J. P., Coffey, D. M., Hawkins, S. M., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2013595117 · Cited by 50
Mei, J., Tian, H., Huang, H.-S., Hsu, C., Liou, Y., Wu, N., Zhang, W., & Chu, T. (2021) · Cell Proliferation · doi:10.1111/cpr.13029 · Cited by 50
PAX8 expression in ovarian surface epithelial cells
Adler, E. K., Mhawech-Fauceglia, P. Y., Gayther, S. A., & Lawrenson, K. (2015) · Human Pathology · doi:10.1016/j.humpath.2015.03.017 · Cited by 49
BRCAMutation Carriers: Breast and Ovarian Cancer Screening Guidelines and Imaging Considerations
Elezaby, M. A., Lees, B. F., Maturen, K. E., Barroilhet, L. M., Wisinski, K. B., Schrager, S., Wilke, L. G., & Sadowski, E. A. (2019) · Radiology · doi:10.1148/radiol.2019181814 · Cited by 49
Emerging and Evolving Ovarian Cancer Animal Models
Bobbs, A. S., Cole, J. M., & Dahl, K. D. C. (2015) · Cancer Growth and Metastasis · doi:10.4137/cgm.s21221 · Cited by 48
Cellular Mechanisms Underlying Intertumoral Heterogeneity
Sutherland, K. D., & Visvader, J. E. (2015) · Trends in cancer · doi:10.1016/j.trecan.2015.07.003 · Cited by 50
Jacob, F., Alam, S., Konantz, M., Liang, C.-Y., Kohler, R. S., Everest‐Dass, A., Huang, Y., Rimmer, N., Fedier, A., Schötzau, A., et al. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2223 · Cited by 48
Spena, C. R., Stefano, L. D., Palazzolo, S., Salis, B., Granchi, C., Minutolo, F., Tuccinardi, T., Fratamico, R., Crotti, S., DaRonco, S., et al. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.04.055 · Cited by 48
Nameki, R. A., Chang, H. S. Y., Reddy, J., Corona, R. I., & Lawrenson, K. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107722 · Cited by 48
Wilson, A. J., Fadare, O., Beeghly-Fadiel, A. C., Son, D., Liu, Q., Zhao, S., Saskowski, J. L., Uddin, M. J., Daniel, C. K., Crews, B. C., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3860 · Cited by 45
Coetzee, S. G., Shen, H. C., Hazelett, D. J., Lawrenson, K., Kuchenbaecker, K. B., Tyrer, J. P., Rhie, S. K., Levanon, K., Karst, A. M., Drapkin, R., et al. (2015) · Human Molecular Genetics · doi:10.1093/hmg/ddv101 · Cited by 44
The promise and challenge of ovarian cancer models.
Hasan, N., Öhman, A., & Dinulescu, D. M. (2015) · PubMed · doi:10.3978/j.issn.2218-676x.2015.01.02 · Cited by 47
Epigenetic remodeling regulates transcriptional changes between ovarian cancer and benign precursors
Elias, K. M., Emori, M. M., Westerling, T., Long, H. W., Budina-Kolomets, A., Li, F., MacDuffie, E., Davis, M., Holman, A. G., Lawney, B. P., et al. (2016) · JCI Insight · doi:10.1172/jci.insight.87988 · Cited by 46
Serous tubal intraepithelial carcinoma (STIC) – clinical impact and management
Weinberger, V., Bednaříková, M., Cibula, D., & Zikán, M. (2016) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2016.1247699 · Cited by 46
Characteristics of in Vivo Model Systems for Ovarian Cancer Studies
Tudrej, P., Kujawa, K. A., Cortez, A. J., & Lisowska, K. M. (2019) · Diagnostics · doi:10.3390/diagnostics9030120 · Cited by 46
Fu, D., Micheli, A. J. D., Bidarimath, M., Ellenson, L. H., Cosgrove, B. D., Flesken‐Nikitin, A., & Nikitin, A. Y. (2020) · Disease Models & Mechanisms · doi:10.1242/dmm.047035 · Cited by 46
Reliable in vitro studies require appropriate ovarian cancer cell lines
Jacob, F., Nixdorf, S., Hacker, N. F., & Heinzelmann-Schwarz, V. A. (2014) · Journal of Ovarian Research · doi:10.1186/1757-2215-7-60 · Cited by 47
Liu, Y., Qiang, W., Xu, X., Dong, R., Karst, A. M., Liu, Z., Kong, B., Drapkin, R., & Wei, J. (2015) · Oncotarget · doi:10.18632/oncotarget.5493 · Cited by 45
PAX8 activates a p53-p21-dependent pro-proliferative effect in high grade serous ovarian carcinoma
Ghannam-Shahbari, D., Jacob, E., Kakun, R. R., Wasserman, T., Korsensky, L., Sternfeld, O., Kagan, J., Bublik, D. R., Aviel‐Ronen, S., Levanon, K., et al. (2018) · Oncogene · doi:10.1038/s41388-017-0040-z · Cited by 45
Shi, K., Yin, X., Cai, M., Yan, Y., Jia, C., Ma, P., Zhang, S., Zhang, Z., Gu, Z., Zhang, M., et al. (2019) · eLife · doi:10.7554/elife.44306 · Cited by 44
Hereditary Ovarian Carcinoma: Cancer Pathogenesis Looking beyond BRCA1 and BRCA2
Samuel, D., Diaz-Barbe, A., Pinto, A., Schlumbrecht, M. P., & George, S. H. L. (2022) · Cells · doi:10.3390/cells11030539 · Cited by 44
Mass Spectrometry–Based Proteomics of Epithelial Ovarian Cancers: A Clinical Perspective
Qian, L., Sun, R., Xue, Z., & Guo, T. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100578 · Cited by 46
The chicken model of spontaneous ovarian cancer
Hawkridge, A. M. (2014) · PROTEOMICS - CLINICAL APPLICATIONS · doi:10.1002/prca.201300135 · Cited by 44
Bai, H., Cao, D., Yang, J., Li, M., Zhang, Z., & Shen, K. (2016) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12771 · Cited by 42
Brown, Y., Hua, S., & Tanwar, P. S. (2023) · Matrix Biology · doi:10.1016/j.matbio.2023.02.004 · Cited by 47
Three-dimensional modeling of ovarian cancer
White, E. A., Kenny, H. A., & Lengyel, E. R. (2014) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2014.07.003 · Cited by 43
Milagre, C. S., Gopinathan, G., Everitt, G. L. A., Thompson, R. G., Kulbe, H., Zhong, H., Hollingsworth, R. E., Grose, R. P., Bowtell, D. D. L., Hochhauser, D., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-1801 · Cited by 41
Role of Fallopian Tubes in the Development of Ovarian Cancer
Corzo, C., Iniesta, M. D., Patrono, M. G., Lu, K. H., & Ramirez, P. T. (2016) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2016.12.007 · Cited by 43
Capellero, S., Erriquez, J., Battistini, C., Porporato, R., Scotto, G., Borella, F., Renzo, M. F. D., Valabrega, G., & Olivero, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020833 · Cited by 42
Ciucci, A., Buttarelli, M., Fagotti, A., Scambia, G., & Gallo, D. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04395-y · Cited by 44
Bergsten, T. M., Burdette, J. E., & Dean, M. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.017 · Cited by 41
Intra-Tumoral Nerve-Tracing in a Novel Syngeneic Model of High-Grade Serous Ovarian Carcinoma
Barr, J. L., Kruse, A., Restaino, A. C., Tulina, N. M., Stückelberger, S., Vermeer, S. J., Williamson, C. S., Vermeer, D. W., Madeo, M., Stamp, J., et al. (2021) · Cells · doi:10.3390/cells10123491 · Cited by 41
Zeppernick, F. A., Meinhold-Heerlein, I. M., & Shih, I. (2014) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.12550 · Cited by 41
The role of reproductive hormones in epithelial ovarian carcinogenesis
Gharwan, H., Bunch, K. P., & Annunziata, C. M. (2015) · Endocrine Related Cancer · doi:10.1530/erc-14-0550 · Cited by 43
Elias, K. M., Tsantoulis, P. K., Tille, J., Vitonis, A. F., Doyle, L. A., Hornick, J. L., Kaya, G., Barnes, L., Cramer, D. W., Puppa, G., et al. (2018) · The Journal of Pathology · doi:10.1002/path.5161 · Cited by 42
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
Yumiceba, V., López-Cortés, A., Pérez-Villa, A., Yumiseba, I., Guerrero, S., García-Cárdenas, J. M., Armendáriz-Castillo, I., Guevara-Ramírez, P., Leone, P. E., Zambrano, A. K., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.585130 · Cited by 40
How can molecular abnormalities influence our clinical approach
Wei, W., Giulia, F. M., Luffer, S., Kumar, R., Wu, B., Tavallai, M., Bekele, R., & Birrer, M. J. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx447 · Cited by 40
The PAX8 cistrome in epithelial ovarian cancer
Adler, E. K., Corona, R. I., Lee, J. M., Rodriguez-Malave, N. I., Mhawech-Fauceglia, P. Y., Sowter, H., Hazelett, D. J., Lawrenson, K., & Gayther, S. A. (2017) · Oncotarget · doi:10.18632/oncotarget.22718 · Cited by 39
Karthikeyan, S., Russo, A., Dean, M., Lantvit, D. D., Endsley, M. P., & Burdette, J. E. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.07.003 · Cited by 40
Tumorigenesis and peritoneal colonization from fallopian tube epithelium
Eddie, S. L., Quartuccio, S. M., hAinmhire, E. Ó., Moyle-Heyrman, G., Lantvit, D., Wei, J., Vanderhyden, B. C., & Burdette, J. E. (2015) · Oncotarget · doi:10.18632/oncotarget.3985 · Cited by 39
Mouse models of epithelial ovarian cancer for preclinical studies
Karakashev, S. V., & Zhang, R. (2021) · 动物学研究 · doi:10.24272/j.issn.2095-8137.2020.382 · Cited by 42
Ovarian Cancer Prevention in High-risk Women
Temkin, S. M., Bergstrom, J., Samimi, G., & Minasian, L. M. (2017) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000000318 · Cited by 39
Ghezelayagh, T. S., Pennington, K. P., Norquist, B. M., Khasnavis, N., Radke, M. R., Kilgore, M., Garcia, R. L., Lee, M. J., Katz, R., Leslie, K. K., et al. (2020) · Gynecologic Oncology · doi:10.1016/j.ygyno.2020.12.007 · Cited by 38
Scattolin, T., Pessotto, I., Cavarzerani, E., Canzonieri, V., Orian, L., Demitri, N., Schmidt, C. S., Casini, A., Bortolamiol, E., Visentin, F., et al. (2022) · European Journal of Inorganic Chemistry · doi:10.1002/ejic.202200103 · Cited by 38
Kar, S., Tyrer, J. P., Li, Q., Lawrenson, K., Aben, K. K. H., Anton‐Culver, H., Antonenkova, N., Chenevix‐Trench, G., Study, O. B. O. T. A. C., and on behalf of the Australian Ovarian Cancer Study Group, et al. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-14-1270 · Cited by 38
Principles of dormancy evident in high-grade serous ovarian cancer
Shepherd, T. G., & Dick, F. A. (2022) · Cell Division · doi:10.1186/s13008-022-00079-y · Cited by 37
Ely, L. K., & Truong, M. (2017) · Journal of Minimally Invasive Gynecology · doi:10.1016/j.jmig.2017.01.001 · Cited by 36
AMPK-Independent LKB1 Activity Is Required for Efficient Epithelial Ovarian Cancer Metastasis
Buensuceso, A. V., Ramos-Valdes, Y., DiMattia, G. E., & Shepherd, T. G. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0530 · Cited by 35
Uno, K., Iyoshi, S., Yoshihara, M., Kitami, K., Mogi, K., Fujimoto, H., Sugiyama, M., Koya, Y., Yamakita, Y., Nawa, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084383 · Cited by 36
Adnexal Lesion Imaging: Past, Present, and Future
Sadowski, E. A., Rockall, A., Thomassin‐Naggara, I., Barroilhet, L. M., Wallace, S., Jha, P., Gupta, A., Shinagare, A. B., Guo, Y., & Reinhold, C. (2023) · Radiology · doi:10.1148/radiol.223281 · Cited by 35
Wellman, T. L., Eckenstein, M., Wong, C., Rincón, M., Ashikaga, T., Mount, S. L., Francklyn, C. S., & Lounsbury, K. M. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-620 · Cited by 35
Murarka, M., Vesley-Gross, Z. I., Essler, J. L., Smith, P. G., Hooda, J., Drapkin, R., & Otto, C. M. (2019) · Journal of Veterinary Behavior · doi:10.1016/j.jveb.2019.04.010 · Cited by 35
Zhu, M., Iwano, T., & Takeda, S. (2019) · Cells · doi:10.3390/cells8080933 · Cited by 35
Yamulla, R. J., Nalubola, S., Flesken‐Nikitin, A., Nikitin, A. Y., & Schimenti, J. C. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108086 · Cited by 35
Immune Checkpoint Blockade in Gynecologic Cancers: State of Affairs
Drakes, M. L., Czerlanis, C. M., & Stiff, P. J. (2020) · Cancers · doi:10.3390/cancers12113301 · Cited by 34
Three-dimensional modeling of the human fallopian tube fimbriae
Eddie, S. L., Quartuccio, S. M., Zhu, J., Shepherd, J. A., Kothari, R., Kim, J. J., Woodruff, T. K., & Burdette, J. E. (2014) · Gynecologic Oncology · doi:10.1016/j.ygyno.2014.12.015 · Cited by 35
Tubal origin of ovarian endometriosis and clear cell and endometrioid carcinoma.
Wang, Y., Mang, M., Wang, Y., Wang, L., Klein, R. R., Kong, B., & Zheng, W. (2015) · PubMed Central · Cited by 34
Ovarian Cancer: From Precursor Lesion Identification to Population-Based Prevention Programs
Sowamber, R., Lukey, A., Huntsman, D. D., & Hanley, G. E. (2023) · Current Oncology · doi:10.3390/curroncol30120741 · Cited by 34
Bourgeois, D. L., Kabarowski, K. A., Porubsky, V. L., & Kreeger, P. K. (2015) · Cancer Cell International · doi:10.1186/s12935-015-0263-4 · Cited by 34
Persistence of fimbrial tissue on the ovarian surface after salpingectomy
Gan, C., Chenoy, R., Chandrasekaran, D., Brockbank, E. C., Hollingworth, A., Vimplis, S., Lawrence, A. C., Jeyarajah, A., Oram, D. H., Deo, N. D., et al. (2017) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2017.06.004 · Cited by 36
UnPAXing the Divergent Roles of PAX2 and PAX8 in High-Grade Serous Ovarian Cancer
Hardy, L. R., Salvi, A., & Burdette, J. E. (2018) · Cancers · doi:10.3390/cancers10080262 · Cited by 34
Identification of a Prognostic Signature Associated With DNA Repair Genes in Ovarian Cancer
Sun, H., Cao, D., Ma, X., Yang, J., Peng, P., Yu, M. Y., Zhou, H., Zhang, Y., Li, L., Huo, X., et al. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00839 · Cited by 34
Shaik, B., Zafar, T., Balasubramanian, K., & Gupta, S. P. (2020) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026620999201111155426 · Cited by 35
Lepage, C. C., Palmer, M. C. L., Farrell, A. C., Neudorf, N. M., Lichtensztejn, Z., Nachtigal, M. W., & McManus, K. J. (2021) · British Journal of Cancer · doi:10.1038/s41416-021-01317-w · Cited by 40
APC2 is critical for ovarian WNT signalling control, fertility and tumour suppression
Mohamed, N.-E., Hay, T., Reed, K. R., Smalley, M. J., & Clarke, A. R. (2019) · BMC Cancer · doi:10.1186/s12885-019-5867-y · Cited by 33
A dog oviduct-on-a-chip model of serous tubal intraepithelial carcinoma
Ferraz, M. D. A. M. M., Nagashima, J. B., Venzac, B., Gac, S. L., & Songsasen, N. (2020) · Scientific Reports · doi:10.1038/s41598-020-58507-4 · Cited by 34
Metadata
- Authors
- Perets, R., Wyant, G. A., Muto, K. W., Bijron, J. G., Poole, B. B., Chin, K. T., Chen, J. Y. H., Ohman, A. W., Stepule, C. D., Kwak, S., Karst, A. M., Hirsch, M. S., Setlur, S. R., Crum, C. P., Dinulescu, D. M., & Drapkin, R.
- Affiliations
- Harvard University (US)
- Brigham and Women's Hospital (US)
- Corresponding author
- Dinulescu, Daniela M.
- Drapkin, Ronny
- ORCID
- Venue
- Cancer Cell
- Publisher
- Elsevier BV
- Published
- 2013-12
- Volume
- 24
- Issue
- 6
- Pages
- 751-765
- ISSN
- 1535-6108 (ISSN-L)
- PMC
- PMC3917315
- OpenAlex
- W2013107316
- Cited by
- 596
- References
- 58
- Citations by year
- 2026: 23 · 2025: 49 · 2024: 35 · 2023: 47 · 2022: 47 · 2021: 46 · 2020: 85 · 2019: 44 · 2018: 42 · 2017: 44 · 2016: 51 · 2015: 49 · 2014: 32
- FWCI
- 52.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Cancer Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- Wellcome Trust
- National Institutes of Health
- National Cancer Institute (R21CA156021, U01CA152990, P50CA105009)
- Topics
- Health Sciences › Medicine › Oncology › Ovarian cancer diagnosis and treatment
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
- Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
- Keywords
- high-grade serous ovarian cancer, serous tubal intraepithelial carcinoma, cancer of unknown primary, BRCA1, BRCA2, TP53, PTEN, peritoneal cancer, precursor lesions, cancer prevention, early detection
- MeSH terms
- PAX8 Transcription Factor, Animals, Cell Transformation, Neoplastic, Epithelium, Fallopian Tube Neoplasms, Female, Mice, Inbred C57BL, Ovarian Neoplasms, Precancerous Conditions, Genes, p53, Cystadenocarcinoma, Serous, Genes, BRCA1, Integrases, Genes, BRCA2, PTEN Phosphohydrolase, Mice, Paired Box Transcription Factors, Neoplasm Grading
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
